Redux Electrolyte Creme Recalled for Low Viscosity Defect
Parker Laboratories is recalling Redux Electrolyte Creme, a highly conductive medical electrolyte product, due to demonstrated low viscosity.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II classification indicates potential for adverse health consequences. As a medical device with documented functional defect (low viscosity) and no reported illnesses or injuries, this meets the rubric criterion for score 3.
Plain-English summary
Redux Electrolyte Creme, Product Ref. 66-04, is a highly conductive electrolyte creme manufactured by Parker Laboratories, Inc. The product is being recalled due to demonstrated low viscosity.
The affected product was distributed worldwide, with U.S. distribution to California, Colorado, Florida, Georgia, Illinois, Maryland, Michigan, Minnesota, North Carolina, Nebraska, New York, Ohio, Pennsylvania, South Carolina, and Texas. International distribution included Australia, Canada, Oman, and Saudi Arabia. The recall affects 217 cases, comprising 1,085 inner boxes and 10,850 individual units.
The recalled lots are A1122010 (expiration date 11/29/25) and A0523002 (expiration date 5/12/26). Consumers and healthcare facilities who have the affected product should contact Parker Laboratories, Inc. for guidance on the recall.
The recalled product
- Product
- Redux Electrolyte Creme, Product Ref. 66-04. Highly conductive electrolyte creme.
- Manufacturer
- Parker Laboratories, Inc.
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Product No. 66-04
- UDI: 20855683006399 (Master)
- 10855683006392 (Inner Box)
- 00855683006395 (Each)
- Lot No. (Expiration Date): A1122010 (11/29/25) and A0523002 (5/12/26).
Distribution
Related recalls
Same manufacturer · Parker Laboratories, Inc.
See all →- ModerateFDA Recalls Conductive Adhesive Gel for Viscosity Defect
FDA (Devices) · 2024-03-06
- ModerateHelix CBD Therapy Cream Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2023-08-30
- ModerateDrug manufacturer recalls Protex hand sanitizer due to manufacturing quality deviations
FDA (Drugs) · 2023-08-30
- ModerateFDA Recalls Helix CBD Clinical Cream for Manufacturing Process Violations
FDA (Drugs) · 2023-08-30
- ModerateHelix Pain Relieving Cream recalled nationwide for manufacturing process violations
FDA (Drugs) · 2023-08-30
Same hazard · viscosity defect
See all →- ModerateTestosterone Gel Recalled for Out-of-Specification Viscosity
FDA (Drugs) · 2023-12-06
- HighTiglutik riluzole oral suspension recalled for failed viscosity specifications
FDA (Drugs) · 2023-11-29
- ModerateAkorn Atropine Sulfate Eye Solution Recalled for Failed Stability Testing
FDA (Drugs) · 2023-02-15